drugset
drugset / Trial / NCT04315051

A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis

NCT04315051 ↗

Phase 2 Terminated 39 enrolled DermBiont, Inc.
Non-randomizedParallel-groupQuadruple-blindTreatment

Summary

Placebo Controlled Trial of the Safety and Efficacy of DBI-001 in Patients with Interdigital Tinea pedis (T. pedis)

Timeline

Start
2019-09-12
Primary completion
2020-06-30
Completion
2020-06-30

Outcome

Outcome not reported

Stopped: “Covid- 19 has shut the clinic”

Drugs

EvaluationDrugModalityDoseRoute
Comparator J. Lividum Unknown — Topical

Indications

tinea pedis